Scinai Immunotherapeutics Ltd banner

Scinai Immunotherapeutics Ltd
NASDAQ:SCNI

Watchlist Manager
Scinai Immunotherapeutics Ltd Logo
Scinai Immunotherapeutics Ltd
NASDAQ:SCNI
Watchlist
Price: 0.76 USD -3.53% Market Closed
Market Cap: $646k

Balance Sheet

Balance Sheet Decomposition
Scinai Immunotherapeutics Ltd

Balance Sheet
Scinai Immunotherapeutics Ltd

Rotate your device to view
Balance Sheet
Currency: USD
Dec-2007 Dec-2008 Dec-2009 Dec-2010 Dec-2011 Dec-2012 Dec-2013 Dec-2014 Dec-2015 Dec-2016 Dec-2017 Dec-2018 Dec-2019 Dec-2020 Dec-2021 Dec-2022 Dec-2023 Dec-2024
Assets
Cash & Cash Equivalents
4
3
8
6
4
3
5
2
9
4
21
20
21
3
17
14
5
2
Cash Equivalents
4
3
8
6
4
3
5
2
9
4
21
20
21
3
17
14
5
2
Short-Term Investments
0
0
0
1
1
1
1
1
1
2
0
0
0
0
0
0
0
0
Total Receivables
0
0
0
0
1
0
0
0
0
0
1
0
0
0
0
0
0
0
Accounts Receivables
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
Other Receivables
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
Other Current Assets
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
1
0
Total Current Assets
4
3
8
7
5
5
6
3
9
7
22
21
21
3
18
14
5
2
PP&E Net
0
0
0
1
1
1
1
1
1
0
2
8
12
14
14
13
12
11
PP&E Gross
0
0
0
1
1
1
0
0
0
0
0
0
0
0
0
13
12
11
Accumulated Depreciation
0
0
0
0
0
1
0
0
0
0
0
0
0
0
0
2
3
4
Intangible Assets
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
Long-Term Investments
0
0
1
1
1
1
1
1
1
1
0
0
0
0
0
0
0
0
Other Long-Term Assets
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
Total Assets
4
N/A
3
-24%
9
+180%
9
-3%
7
-18%
6
-13%
7
+20%
5
-36%
11
+124%
8
-26%
23
+200%
28
+21%
34
+18%
18
-47%
32
+81%
27
-16%
17
-35%
13
-23%
Liabilities
Accounts Payable
0
0
1
1
0
0
1
0
0
0
2
6
5
1
2
1
1
0
Accrued Liabilities
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
2
1
1
Short-Term Debt
0
0
0
0
0
0
0
0
0
0
0
0
0
19
0
0
0
0
Other Current Liabilities
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
Total Current Liabilities
0
0
1
1
0
0
1
0
0
0
2
6
5
20
2
2
2
2
Long-Term Debt
0
0
0
0
0
0
0
0
0
0
0
25
38
2
22
20
19
0
Other Liabilities
0
0
0
0
0
0
0
0
2
1
5
6
9
0
0
6
1
1
Total Liabilities
0
N/A
0
-15%
1
+159%
1
+45%
0
-39%
0
-40%
1
+94%
0
-9%
2
+314%
1
-42%
7
+527%
37
+401%
52
+43%
22
-57%
25
+10%
29
+17%
22
-24%
3
-84%
Equity
Common Stock
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
6
Retained Earnings
1
2
4
7
10
12
16
16
20
23
35
57
93
101
117
116
122
118
Additional Paid In Capital
5
5
12
15
17
18
23
20
28
29
52
48
74
97
125
116
120
124
Other Equity
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
2
2
2
Total Equity
4
N/A
3
-25%
8
+181%
8
-5%
7
-16%
6
-12%
7
+16%
4
-38%
9
+102%
7
-23%
16
+143%
8
N/A
19
-126%
5
+76%
8
N/A
2
N/A
5
-160%
10
N/A
Total Liabilities & Equity
4
N/A
3
-24%
9
+180%
9
-3%
7
-18%
6
-13%
7
+20%
5
-36%
11
+124%
8
-26%
23
+200%
28
+21%
34
+18%
18
-47%
32
+81%
27
-16%
17
-35%
13
-23%
Shares Outstanding
Common Shares Outstanding
2
2
3
4
4
4
5
5
14
14
26
26
40
46
74
989
1 857
3 412